BDR Pharmaceuticals set to launch maiden generic Cabozantinib to treat metastatic medullary thyroid…
The company is amongst the first to receive permission from DCGI and launch the drug in India
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.